Scaling a Medtech Company featuring CEO Ramin Mousavi

For early-stage medical device companies, leverage isn’t just a financial term. It’s strategic.
In this episode of Medtech Snapshot, Ramin Mousavi, CEO of CathWorks, breaks down what it looks like to evolve from a first-generation product to a scalable second-generation platform.

The conversation centers around outsourcing and partnership strategy. Many small OEMs rely heavily on outside manufacturing, sterilization, and supply chain partners. But not all partnerships are equal.
Ramin emphasizes three things founders should look for:

1. Strategic flexibility — Can your partner help you shift production globally if tariffs or regional economics change?
2. Replicability — Can your manufacturing model scale across geographies as your company grows?
3. Insight — Can your partners bring innovation to the table that you might not see internally?

One of the most compelling examples comes from CathWorks’ own evolution. Their first-generation capital equipment shipped on pallets. Their next-generation system is being designed small enough for a rep to carry directly into a hospital.
That kind of iteration is operational leverage. Smaller footprint means lower freight costs, easier deployment, and greater global scalability.
The takeaway?
Innovation doesn’t stop at the device. Packaging, logistics, and manufacturing strategy can be just as important to long-term success.

---

Looking for more support?
If you have questions about this topic or want to explore how our team can help with your medtech project, contact us here.
Want to see what we do?
Visit our Services page or contact us directly to talk through your project and see if we’re the right fit.